or
forgot password
  • cancer clinical trials in tampa, FL

  • Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
    Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    H. Lee Moffitt Cancer Center/University of South Florida H. Lee Moffitt SC
    Tampa, Florida 33612
    Metastatic Breast Cancer
    Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Prostate Cancer
    Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Combined Type Small Cell Lung Cancer, Fusiform Type Small Cell Lung Cancer, Lymphocyte-like Type Small Cell Lung Cancer, Polygonal Type Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
    Moffitt Cancer Center
    Tampa, Florida 33612
    Hodgkin Lymphoma
    A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
    University of South Florida, Carol and Frank Morsani Center for Advanced Healthcare
    Tampa, Florida 33612
    Actinic Keratosis
    A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors
    H. Lee Moffitt Cancer Center & Research Institute Moffitt SC 2
    Tampa, Florida 33612
    Solid Tumors Harboring a BRAF V600 Mutation
    Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
    Moffitt Cancer Center and Research Institute, H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Cervical Cancer
    Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
    H Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Unresectable Hepatocellular Carcinoma
    Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
    Moffitt Cancer Center
    Tampa, Florida 33612
    Metastatic Castration Resistant Prostate Cancer
    A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
    Synta Pharmaceuticals Investigative Site
    Tampa, Florida 33612
    Non Small Cell Lung Cancer
    Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Malignant Neoplasm of Breast, Breast Radiotherapy, Breast Diseases, Ductal Breast Carcinoma, Intraoperative Radiotherapy
    Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation.
    Moffitt Cancer Center
    Tampa, Florida 33612
    Metastatic Soft Tissue Sarcoma
    Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
    H. Lee Moffitt Cancer Center/University of South Florida Moffitt 4
    Tampa, Florida 33612
    Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme
    Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C
    Moffitt Cancer Center
    Tampa, Florida 33612
    Advanced Gastrointestinal Malignancies
    A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
    Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Primary Cutaneous Anaplastic Large Cell Lymphoma,, Mycosis Fungoides, Cutaneous T-Cell Lymphoma
    Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Prostate Cancer
    Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Liver Cancer, Pancreatic Cancer
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    A Clinical Study Testing The Safety and Efficacy of CH5424802/RO5424802 in Patients With ALK Positive Non-Small Cell Lung Cancer
    Moffitt Cancer Center
    Tampa, Florida 33612
    ALK-Rearranged Non-Small Cell Lung Cancer
    Stress Management Training for Latinas Receiving Chemotherapy
    Moffitt Cancer Center
    Tampa, Florida 33612
    Cancer, Stress
    Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Urothelial Carcinoma
    Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
    Tampa General Hospital
    Tampa, Florida 33606
    Cytomegalovirus Infections
    Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Advanced BRAF-mutant Cancers
    A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
    H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC
    Tampa, Florida 33612
    Breast Cancer
    Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
    H. Lee Moffitt Cancer Center/University of South Florida H Lee Moffitt 2
    Tampa, Florida 33612
    Pancreatic Neuroendocrine Tumors (pNET)
    Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
    Moffitt Cancer Center
    Tampa, Florida 33612
    Neoplasms by Site
    Smoking Relapse-Prevention Intervention for Cancer Patients
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Smoking Cessation
    Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
    H. Lee Moffitt Cancer Center/University of South Florida Dept of Onc
    Tampa, Florida 33612
    Castration-resistant Prostate Cancer
    Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Pulmonary Relapse of Osteosarcoma
    Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
    Call for Information (Investigational Site 0026)
    Tampa, Florida 33617
    Genital Warts, Anal Cancer, Anal Intraepithelial Neoplasia
    Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Melanoma
    Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Metastatic Melanoma
    Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer at Moffitt Cancer Center
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Pancreatic Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Lymphoma
    Evaluating Biobanking Educational Tools
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Neoplasm
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Non-Squamous Cell Non-small Cell Lung Cancer
    CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Malignant Pleural Mesothelioma
    Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
    H.Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Chronic Graft Versus Host Disease
    LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
    H. Lee Moffitt Cancer Center & Research Institute SC-3
    Tampa, Florida 33612
    Non-Small Cell Lung Cancer
    Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    High Risk Acute Myeloid Leukemia
    A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    For Donors:, Related Donors Donating PBSC to a Family Member, For Recipients:, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia
    Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
    H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Tampa, Florida 33612
    Metastatic Breast Cancer
    Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Metastatic Melanoma
    Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Chronic Phase Chronic Myeloid Leukemia
    A Phase III Study of Oral LDE225 Versus (vs) Temozolomide (TMZ) in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
    H. Lee Moffitt Cancer Center & Research Institute Dept Oncology
    Tampa, Florida 33612
    Medulloblastoma
    A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Non-small Cell Lung Cancer(NSCLC)
    Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
    H Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Acute GVH Disease
    Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
    H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
    Tampa, Florida 33612
    Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma
    Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Cutaneous T-Cell Lymphoma
    Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
    H. Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Low to Intermediate-1 MDS
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt Cancer Ctr (67)
    Tampa, Florida 33612
    CML
    Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    CANCER, NOS
    GTX-RT in Borderline Resectable Pancreatic Cancer
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Pancreatic Cancer
    Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Melanoma
    Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle
    Moffit Cancer Center
    Tampa, Florida 33612
    Pancreatic Mass, Abnormal Lymph Nodes, Mediastinal Masses, Gastric Submucosal Masses
    A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Myelomonocytic Leukemia
    Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
    H. Lee Moffitt Cancer Center/University of South Florida SC - 5
    Tampa, Florida 33612
    Chronic Myelogenous Leukemia
    A Safety Study of SGN-CD19A for Leukemia and Lymphoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Burkitt Lymphoma, Precursor B-cell Lymphoblastic Leukemia-Lymphoma
    A Safety Study of SGN-CD19A for B-Cell Lymphoma
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor B-cell Lymphoblastic Leukemia-Lymphoma
    Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Metastatic Breast Cancer
    Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-versus-host Disease
    H Lee Moffitt Cancer Center
    Tampa, Florida 33612
    Graft Versus Host Disease
    A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Breast Cancer
    Colorectal Cancer Awareness, Research, Education and Screening (CARES)
    H. Lee Moffitt Cancer Center and Research Institute
    Tampa, Florida 33612
    Colorectal Cancer
    Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
    H.Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Multiple Myeloma
    Effect of Lung Cancer Diagnoses on Family Behaviors
    Moffitt Cancer Center
    Tampa, Florida 33612
    Lung Cancer, Blood Relatives of Patient w/Lung Cancer, Cigarette Smokers
    Analyses of Human Samples Collected in Clinical Trials
    H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612
    Pharmacokinetics